Cholesterol-lowering drug Lipitor reduces mortality in study

08/29/2011 | CNN/The Chart blog

A follow-up study in the European Heart Journal found that patients taking Pfizer's cholesterol-lowering statin Lipitor had a 14% lower death rate compared with placebo users. The finding was attributed mainly to a significant reduction in mortality from respiratory and infectious diseases. A clinical trial of Lipitor ended in 2003 after the statin demonstrated effectiveness in preventing stroke and heart attack.

View Full Article in:

CNN/The Chart blog

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC